Andrographis paniculata chemistry, the preclinical Cys62 p50 NF-κB mechanism, trials of specific extracts for ARI symptoms, pharmacokinetics, and current allergy-safety signals.

October 9, 2026

Knowledge · Nutrition

Mast Cell Activation Syndrome: Mediators, Diagnosis, and Limits of Therapy

How to distinguish MCAS from mastocytosis and allergy; event-related tryptase, histamine, PGD₂, leukotrienes, diagnostic criteria, treatment evidence, and safety limits.

October 9, 2026

All materials

Material type

Area

Andrographis, andrographolide, NF-κB p50, and acute respiratory infection evidence

Popular tags

Mast Cell Activation Syndrome: Mediators, Diagnosis, and Limits of Therapy